LU80094A1 - Verfahren zur herstellung von neuen 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren - Google Patents
Verfahren zur herstellung von neuen 2-pyridyl- und 2-pyrimidylaminobenzoesaeurenInfo
- Publication number
- LU80094A1 LU80094A1 LU80094A LU80094A LU80094A1 LU 80094 A1 LU80094 A1 LU 80094A1 LU 80094 A LU80094 A LU 80094A LU 80094 A LU80094 A LU 80094A LU 80094 A1 LU80094 A1 LU 80094A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- pyrimidylaminobenzoesaurs
- pyridyl
- producing new
- producing
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772735919 DE2735919A1 (de) | 1977-08-10 | 1977-08-10 | Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU80094A1 true LU80094A1 (de) | 1979-09-07 |
Family
ID=6016013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU80094A LU80094A1 (de) | 1977-08-10 | 1978-08-08 | Verfahren zur herstellung von neuen 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US4241068A (de) |
| JP (1) | JPS5430177A (de) |
| AT (1) | AT370415B (de) |
| AU (1) | AU520240B2 (de) |
| BE (1) | BE869640A (de) |
| BG (1) | BG30472A1 (de) |
| CA (1) | CA1111037A (de) |
| CH (1) | CH649289A5 (de) |
| CS (1) | CS202506B2 (de) |
| DD (1) | DD140351A5 (de) |
| DE (1) | DE2735919A1 (de) |
| DK (1) | DK148019C (de) |
| ES (5) | ES472143A1 (de) |
| FI (1) | FI71555C (de) |
| FR (1) | FR2400017A1 (de) |
| GB (1) | GB2002764B (de) |
| GR (1) | GR65024B (de) |
| HU (1) | HU179933B (de) |
| IE (1) | IE47228B1 (de) |
| IT (1) | IT1107960B (de) |
| LU (1) | LU80094A1 (de) |
| MX (1) | MX5672E (de) |
| NL (1) | NL7808319A (de) |
| NO (1) | NO152605C (de) |
| NZ (1) | NZ188101A (de) |
| PH (1) | PH19117A (de) |
| PL (2) | PL115889B1 (de) |
| PT (1) | PT68407A (de) |
| SE (1) | SE444170B (de) |
| SU (2) | SU735168A3 (de) |
| YU (1) | YU40832B (de) |
| ZA (1) | ZA784501B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3100516A1 (de) * | 1981-01-10 | 1982-08-12 | C.H. Boehringer Sohn, 6507 Ingelheim | Pyridylaminobenzoesaeuren, ihre herstellung und verwendung |
| FR2533567A1 (fr) * | 1982-09-23 | 1984-03-30 | Ki I Farmakologii | 2-(orthocarboxyphenylamino)-6h-pyrimido (2,1-b)-quinazolone-6 et ses derives, leur procede de preparation et leur application therapeutique |
| US4610991A (en) * | 1983-04-18 | 1986-09-09 | Sterling Drug Inc. | Antihypertensive pyridylaminobenzamide compounds |
| JPS60100559A (ja) * | 1983-11-05 | 1985-06-04 | Morishita Seiyaku Kk | ２−アニリノ−１，６−ジヒドロ−６−オキソ−５−ピリミジンカルボン酸誘導体，その製法及び該化合物を含有する抗アレルギ−剤 |
| US4584379A (en) * | 1985-01-22 | 1986-04-22 | Merrell Dow Pharmaceuticals Inc. | Isoquinoline thromboxane synthetase inhibitors |
| EP0219308B1 (de) * | 1985-10-16 | 1991-10-23 | Merck Frosst Canada Inc. | 2-Substituierte Chinoline |
| GB9615950D0 (en) * | 1996-07-30 | 1996-09-11 | Univ Warwick | Variable reluctance machines |
| US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1064259A (en) * | 1963-12-19 | 1967-04-05 | Union Pharma Scient Appl | New derivatives of 2-anilino-nicotinic acid and process for their preparation |
| GB1162287A (en) * | 1967-11-07 | 1969-08-20 | Union Pharma Scient Appl | New Salts of 2-Anilino-Nicotinic Acids |
| GB1264798A (de) * | 1968-07-10 | 1972-02-23 | ||
| ES416847A1 (es) * | 1973-07-12 | 1976-03-01 | Hermes Sa Lab | Procedimiento para la obtencion de derivados del acido ni- cotinico. |
-
1977
- 1977-08-10 DE DE19772735919 patent/DE2735919A1/de active Granted
-
1978
- 1978-06-27 FI FI782039A patent/FI71555C/fi not_active IP Right Cessation
- 1978-07-07 GR GR56729A patent/GR65024B/el unknown
- 1978-07-28 ES ES472143A patent/ES472143A1/es not_active Expired
- 1978-07-28 AT AT0549278A patent/AT370415B/de not_active IP Right Cessation
- 1978-07-31 PH PH21447A patent/PH19117A/en unknown
- 1978-08-07 CH CH8381/78A patent/CH649289A5/de not_active IP Right Cessation
- 1978-08-07 MX MX787292U patent/MX5672E/es unknown
- 1978-08-08 BG BG7840623A patent/BG30472A1/xx unknown
- 1978-08-08 IT IT50642/78A patent/IT1107960B/it active
- 1978-08-08 LU LU80094A patent/LU80094A1/de unknown
- 1978-08-08 SU SU782646404A patent/SU735168A3/ru active
- 1978-08-08 DD DD78207180A patent/DD140351A5/de unknown
- 1978-08-09 DK DK351978A patent/DK148019C/da not_active IP Right Cessation
- 1978-08-09 YU YU1916/78A patent/YU40832B/xx unknown
- 1978-08-09 GB GB7832731A patent/GB2002764B/en not_active Expired
- 1978-08-09 HU HU78BO1727A patent/HU179933B/hu not_active IP Right Cessation
- 1978-08-09 NL NL787808319A patent/NL7808319A/xx not_active Application Discontinuation
- 1978-08-09 IE IE1618/78A patent/IE47228B1/en unknown
- 1978-08-09 SE SE7808530A patent/SE444170B/sv not_active IP Right Cessation
- 1978-08-09 PT PT68407A patent/PT68407A/de unknown
- 1978-08-09 CA CA308,978A patent/CA1111037A/en not_active Expired
- 1978-08-09 BE BE78189801A patent/BE869640A/xx not_active IP Right Cessation
- 1978-08-09 ZA ZA784501A patent/ZA784501B/xx unknown
- 1978-08-09 PL PL1978215270A patent/PL115889B1/pl unknown
- 1978-08-09 JP JP9626278A patent/JPS5430177A/ja active Granted
- 1978-08-09 NZ NZ188101A patent/NZ188101A/xx unknown
- 1978-08-09 NO NO782707A patent/NO152605C/no unknown
- 1978-08-09 AU AU38772/78A patent/AU520240B2/en not_active Expired
- 1978-08-09 PL PL1978208942A patent/PL115778B1/pl unknown
- 1978-08-09 CS CS785205A patent/CS202506B2/cs unknown
- 1978-08-10 FR FR7823617A patent/FR2400017A1/fr active Granted
- 1978-11-28 ES ES475457A patent/ES475457A1/es not_active Expired
- 1978-11-28 ES ES475456A patent/ES475456A1/es not_active Expired
-
1979
- 1979-05-16 ES ES480623A patent/ES480623A1/es not_active Expired
- 1979-05-16 ES ES480622A patent/ES480622A1/es not_active Expired
- 1979-05-21 SU SU792765447A patent/SU886743A3/ru active
- 1979-08-07 US US06/064,355 patent/US4241068A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT367425B (de) | Verfahren zur herstellung von neuen cephemderivaten | |
| AT367426B (de) | Verfahren zur herstellung von neuen cephemderivaten | |
| AT372093B (de) | Verfahren zur herstellung von neuen corticoid-17- alkylcarbonaten | |
| AT362065B (de) | Verfahren zur herstellung von neuen pleuromutilinglycosidderivaten | |
| LU79212A1 (de) | Verfahren zur herstellung von neuen 4-acylamino-phenylaethanolaminen | |
| AT363182B (de) | Verfahren zur herstellung von neuen cephemderivaten | |
| AT368753B (de) | Verfahren zur herstellung von neuen azacycloalkanen | |
| AT371455B (de) | Verfahren zur herstellung von neuen prostanderivaten | |
| AT368137B (de) | Verfahren zur herstellung von neuen 4-amino-5alkylthiopyrimidinen | |
| AT366368B (de) | Verfahren zur herstellung von neuen chinolylguanidinen | |
| AT357673B (de) | Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten | |
| AT366032B (de) | Verfahren zur herstellung von moranolin und n-methylmoranolin | |
| AT371463B (de) | Verfahren zur herstellung von neuen gammabutyrolactonen und gamma-butyrothiolactonen | |
| LU80094A1 (de) | Verfahren zur herstellung von neuen 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren | |
| AT361622B (de) | Verfahren zur herstellung von neuen anthra- cyclinglycosid-anitbiotika | |
| AT365591B (de) | Verfahren zur herstellung von neuen indolderivaten | |
| AT361489B (de) | Verfahren zur herstellung von neuen pyrrolochinoxalinonen und pyrrolobenzdia- zepinonen | |
| AT362368B (de) | Verfahren zur herstellung von neuen oxazolidin- 2-on-derivaten | |
| AT372690B (de) | Verfahren zur herstellung von neuen polyhydantoinen | |
| AT363623B (de) | Verfahren zur herstellung von neuen prostaglandinderivaten | |
| AT360676B (de) | Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen | |
| ATA750578A (de) | Verfahren zur herstellung von neuen pyridothiazo- linen | |
| AT365203B (de) | Verfahren zur herstellung von neuen 9-fluorprednisolon-derivaten | |
| ATA405677A (de) | Verfahren zur herstellung von neuen bufadienolid- und bufatrienolidaethern | |
| AT359517B (de) | Verfahren zur herstellung von neuen alfa- -halogenaethylcarbamidsaeurehalogeniden |